BioMarin Pharmaceutical Inc. is a California-based biopharmaceutical company that develops and sells treatments for rare genetic diseases. Its filings show it lobbied Congress on health and Medicare/Medicaid issues, budget and appropriations bills, tariff matters, and tax code items — including reauthorization of a rare pediatric disease priority review voucher program and several bills to accelerate kids’ access to care. The company appears to do this to protect access, reimbursement, and policy affecting its therapies.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN EDWARD GREISSING
The latest disclosures for this client.
BIOMARIN PHARMACEUTICAL INC.
2ABIOMARIN PHARMACEUTICAL INC.
2AThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
BIOMARIN PHARMACEUTICAL INC.
KATHRYN LOWELL
BIOMARIN PHARMACEUTICAL INC.
DANIEL MAYNE
BIOMARIN PHARMACEUTICAL INC.
BIOMARIN PHARMACEUTICAL INC.
Q2BIOMARIN PHARMACEUTICAL INC.
Q1BIOMARIN PHARMACEUTICAL INC.
Q4BIOMARIN PHARMACEUTICAL INC.
Q3BIOMARIN PHARMACEUTICAL INC.
Q2BIOMARIN PHARMACEUTICAL INC.
Q1